Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 - WDRB 41 Louisville News

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/wilms_tumor_nephroblastoma_global_clinical_trials_review.html

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014" provides data on the Wilms' Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms' Tumor (Nephroblastoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wilms' Tumor (Nephroblastoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Introduction 6
Wilms' Tumor (Nephroblastoma) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Wilms' Tumor (Nephroblastoma) 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Wilms' Tumor (Nephroblastoma) 29
Apr 23, 2012: Experimental Drug NVP-AEW541 Shows Promise In Treating Wilms Tumor, ICR Study Shows 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Spectrum Pharmaceuticals, Inc. 30
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 30
Laboratorio Elea S.A.C.I.F. and A 31
Clinical Trial Overview of Laboratorio Elea S.A.C.I.F. and A 31
Jennerex Biotherapeutics, Inc. 32
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Children's Oncology Group 33
Clinical Trial Overview of Children's Oncology Group 33
National Cancer Institute 35
Clinical Trial Overview of National Cancer Institute 35
The University of Texas M. D. Anderson Cancer Center 37
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 37
Memorial Sloan Kettering Cancer Center 38
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 38
University of Michigan Comprehensive Cancer Center 39
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 39
Emory University 40
Clinical Trial Overview of Emory University 40
University Hospitals of Leicester NHS Trust 41
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 41
Cancer Research UK 42
Clinical Trial Overview of Cancer Research UK 42
Five Key Clinical Profiles 43
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71

List of Tables

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014* 30
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorio Elea S.A.C.I.F. and A, 2014* 31
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2014* 32
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 33
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 35
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 37
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 38
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2014* 39
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 40
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 41
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2014* 42

List of Figures

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 69

Read the full report:
Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/wilms_tumor_nephroblastoma_global_clinical_trials_review.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WDRB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.